Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Vaccine|April 15, 2014
Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?Mark Jit, Yoon Hong Choi, Jean-François Laprise, et al.
BMC Medicine|May 23, 2022
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemicAurélie Godbout, Mélanie Drolet, Myrto Mondor, et al.
Sexually Transmitted Diseases|January 25, 2021
The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018Harrell W Chesson, Jean-François Laprise, Marc Brisson, et al.
Sexually Transmitted Diseases|June 27, 2009
Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in CanadaErich V Kliewer, Alain A Demers, Lawrence Elliott, et al.
The Lancet. Global Health|December 15, 2022
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
The Lancet. Infectious Diseases|August 28, 2012
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|February 1, 2013
Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsMark Jit, Carol Levin, Marc Brisson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2019
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling studyMélanie Drolet, Zhou Zhou, Chantal Sauvageau, et al.
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometryYunsheng Hsieh, Gangfeng Wang, Yuguang Wang, et al.
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Vaccine|April 15, 2014
Two-dose strategies for human papillomavirus vaccination: how well do they need to protect?Mark Jit, Yoon Hong Choi, Jean-François Laprise, et al.
BMC Medicine|May 23, 2022
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemicAurélie Godbout, Mélanie Drolet, Myrto Mondor, et al.
Sexually Transmitted Diseases|January 25, 2021
The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018Harrell W Chesson, Jean-François Laprise, Marc Brisson, et al.
Sexually Transmitted Diseases|June 27, 2009
Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in CanadaErich V Kliewer, Alain A Demers, Lawrence Elliott, et al.
The Lancet. Global Health|December 15, 2022
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
The Lancet. Infectious Diseases|August 28, 2012
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|February 1, 2013
Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsMark Jit, Carol Levin, Marc Brisson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2019
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling studyMélanie Drolet, Zhou Zhou, Chantal Sauvageau, et al.
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometryYunsheng Hsieh, Gangfeng Wang, Yuguang Wang, et al.
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
Pageof 15